Content Topics

Climate 58

View All

Alta debuts with $5.1 million Seed to sustainably separate critical minerals using advanced biochemistry

By James Hardiman

Radiant Industries raises $100 million DCVC Climate–led Series C to speed microreactors to market

By Dr. Rachel Slaybaugh

Climate tech’s lemons-to-lemonade moment: how the private sector can ensure a durable, clean American industrial renaissance

Deep Tech Opportunities Report

DCVC DTOR 2024: It’s time to start making AI greener

Computational Bio & Chem 26

View All

Manufacturing cancer-killing T cells inside the body

By Dr. John Hamer, Dr. Kiersten Stead

DCVC Announcements

DCVC closes $700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report

DCVC Bio III closes at $400 million

By Dr. John Hamer, Dr. Kiersten Stead, Matthew Ocko, Zachary Bogue

Umoja gets FDA approval to begin clinical trials of its transformative in vivo gene therapy for cancer

By Dr. Kiersten Stead, Dr. John Hamer

Cybersecurity, Security, & Defense 14

View All

The hard problem of hardware attacks

By James Hardiman

Deep tech to defeat deepfakes: Reality Defender is on the case

The next cybersecurity battleground

Jon Gruen: Fortem Technologies

Enterprise Enablement 7

View All

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC companies are at the forefront of better generative AI: Databricks to acquire MosaicML for $1.3B

By Matthew Ocko

Confluent IPO: Data In (Upward) Motion

By Matthew Ocko

DCVC Announcements

2021 and Deep Tech: Reasons for Optimism

Finance & Insurance 3

View All

DCVC proud to back ElectronX in its quest to build the first-ever direct-access regulated derivatives exchange for the electric power markets

Deep Tech Opportunities Report

Cryptography for the real world

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

Foundational Technology 7

View All

Deep Tech Opportunities Report

DCVC DTOR 2024: With quantum computing, we invest in the picks and shovels

Odyssey is delivering powerful new 3D generative AI tools to Hollywood

IBM builds Q-CTRL’s error-suppression software into its quantum computing service

By James Hardiman

MosaicML announces right advance at right time—high-performance, affordable, secure, explainable AI

By Matthew Ocko

Industrial Transformation 30

View All

Alta debuts with $5.1 million Seed to sustainably separate critical minerals using advanced biochemistry

By James Hardiman

Clearing the Docks

By James Hardiman

Climate tech’s lemons-to-lemonade moment: how the private sector can ensure a durable, clean American industrial renaissance

Deep Tech Opportunities Report

DCVC DTOR 2024: Agility Robotics is a real-world case study in operational data

Smart Agriculture 13

View All

DCVC Announcements

DCVC closes $700 million+ in new funds for a healthier planet and healthier lives; releases second-annual Deep Tech Opportunities Report and first-annual DCVC Climate Impact Report

CH4 Global set to launch world's first commercial scale Asparagopsis production facility

DCVC Announcements

DCVC Welcomes 2022

Eliminating Cow Burps to Save Civilization

By Dr. John Hamer, Zachary Bogue

Space 10

View All

DCVC anchors $150 million in financing for Impulse Space to deliver precise, fast, and affordable maneuverability of satellites within and between orbits

By Matthew Ocko, Matt O'Connell

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC Announcements

DCVC Welcomes 2022

On Going to Space

TechBio 4

View All

Deep Tech Opportunities Report

DCVC DTOR 2024: TechBio is emerging as the data-centric, AI-native counterweight to biotech

Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis

By Jason Pontin

DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases

By Jason Pontin, Zachary Bogue

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

TechMed 21

View All

Proprio's Physical AI at the 2025 JPM Healthcare Conference

The Somatic AI revolution: How TechMed is reshaping healthcare as we know it

Valar Labs introduces a smarter cancer test

By James Hardiman

The TechMed movement has arrived

By Alan Cohen, Zachary Bogue